Protéines recombinantes
Protéines modifiées ou manipulées codées par l'ADN recombinant et adaptées à divers usages, notamment la modification de séquences génétiques, la production massive de protéines et la fabrication de produits commerciaux.
marques:
Pepro Tech Inc
Effacer toutes les sélections
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Rechercher dans les résultats
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
19
résultats
| Poids moléculaire (g/mol) | 22.7 kDa |
|---|---|
| Numéro d'enregistrement | P20294 |
| Séquence | AFAEQTPLTL HRRDLCSRSI WLARKIRSDL TALMESYVKH QGLNKNINLD SVDGVPVAST DRWSEMTEAE RLQENLQAYR TFQGMLTKLL EDQRVHFTPT EGDFHQAIHT LMLQVSAFAY QLEELMVLLE QKIPENEADG MPATVGDGGL FEKKLWGLKV LQELSQWTVR SIHDLRVISS HQMGISALES HYGAKDKQM |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to stimulate proliferation of human TF-1 cells using a concentration range of 25.0-35.0 ng/ml |
| Conjugué | Unconjugated |
| Nom | Rat CNTF, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | CNTF |
| Nom usuel | CNTF |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | AI429687; Ciliary neurotrophic factor; ciliary neurotropic factor; Cntf; HCNTF; H-CNTF |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to stimulate proliferation of human TF-1 cells using a concentration range of 25.0-35.0 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 25707 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18.4 kDa |
|---|---|
| Numéro d'enregistrement | P21581 |
| Séquence | MQEICRNPVT DNVKDITKLV ANLPNDYMIT LNYVAGMDVL PSHCWLRDMV THLSVSLTTL LDKFSNISEG LSNYSIIDKL GKIVDDLVAC MEENAPKNVK ESLKKPETRN FTPEEFFSIF NRSIDAFKDF MVASDTSDCV LSSTLGPEKD SRVSVTKPFM LPPVA |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by the dose-dependent stimulation of the proliferation of the human TF-1 cells. The expected ED50 for this effect is 20 - 40 ng/ml |
| Conjugué | Unconjugated |
| Nom | Rat SCF, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | KITLG |
| Nom usuel | SCF |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | 710-712; blz; c-Kit ligand; Clo; cloud gray; Con; contrasted; CSF; DCUA; DFNA69; DKFZp686F2250; familial progressive hyperpigmentation 2; FPH2; FPHH; Gb; grizzle-belly; hematopoietic growth factor KL; H-SCF; Kit ligand; Kitl; Kitlg; kit-ligand; KL-1; Mast cell growth factor; MGF; M-SCF; Processed kit ligand; SCF; SF; SHEP7; sKITLG; Sl; SLF; Soluble KIT ligand; Steel factor; steel factor/kit ligand; stem cell factor; stem cell factor KL-1; stem cell factor, CSF |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by the dose-dependent stimulation of the proliferation of the human TF-1 cells. The expected ED50 for this effect is 20 - 40 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 60427 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17 kDa |
|---|---|
| Numéro d'enregistrement | O43508 |
| Séquence | MKGRKTRARR AIAAHYEVHP RPGQDGAQAG VDGTVSGWEE ARINSSSPLR YNRQIGEFIV TRAGLYYLYC QVHFDEGKAV YLKLDLLVDG VLALRCLEEF SATAASSLGP QLRLCQVSGL LALRPGSSLR IRTLPWAHLK AAPFLTYFGL FQVH |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Assay 1: The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 10 ng/ml Assay 2: TWEAK weakly induces the death of HT29 cells when cultured in the presence of IFN-gamma. The ED50 for this effect is between 30-45 ng/ml |
| Conjugué | Unconjugated |
| Nom | Human TWEAK, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Tnfsf12 |
| Nom usuel | TWEAK |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | APO3 ligand; APO3/DR3 ligand; APO3L; Dr3l; Dr3lg; LOW QUALITY PROTEIN: tumor necrosis factor ligand superfamily member 12; MGC129581; MGC20669; TNF superfamily member 12; TNF-related weak inducer of apoptosis; TNFSF12; TNLG4A; tumor necrosis factor (ligand) superfamily member 12; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor ligand 4 A; tumor necrosis factor ligand superfamily member 12; Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form; tumor necrosis factor superfamily member 12; TWEAK; UNQ181/PRO207; zgc:153941 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Assay 1: The ED50 as determined by the dose-dependent stimulation of IL-8 production by human PBMC is less than 10 ng/ml Assay 2: TWEAK weakly induces the death of HT29 cells when cultured in the presence of IFN-gamma. The ED50 for this effect is between 30-45 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 8742 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 15 kDa |
|---|---|
| Numéro d'enregistrement | Q9ES17 |
| Séquence | MHKSSPQGPD RLLIRLRHLI DIVEQLKIYE NDLDPELLSA PQDVKGHCEH AAFACFQKAK LKPSNPGNNK TFIIDLVAQL RRRLPARRGG KKQKHIAKCP SCDSYEKRTP KEFLERLKWL LQKMIHQHLS |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of human ANBL-6 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Conjugué | Unconjugated |
| Nom | Mouse IL-21, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IL21 |
| Nom usuel | IL-21 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | CVID11; C x 2; il 21; IL21; IL-21; ILN; Interleukin; interleukin 21; Interleukin21; interleukin-21; interleukin-21 isoform; porcine interleukin-21; Za11 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to stimulate the proliferation of human ANBL-6 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 60505 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 14 kDa |
|---|---|
| Numéro d'enregistrement | P15248 |
| Séquence | MQGCPTLAGI LDINFLINKM QEDPASKCHC SANVTSCLCL GIPSDNCTRP CFSERLSQMT NTTMQTRYPL IFSRVKKSVE VLKNNKCPYF SCEQPCNQTT AGNALTFLKS LLEIFQKEKM RGMRGKI |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of human MO7e cells. The expected ED50 is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Conjugué | Unconjugated |
| Nom | Human IL-9, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Il9 |
| Nom usuel | IL-9 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | cytokine P40; homolog of mouse T cell and mast cell growth factor 40; HP40; IL9; IL-9; ILN; Interleukin; interleukin 9; Interleukin9; interleukin-9; P40; p40 cytokine; p40 T-cell and mast cell growth factor; T-cell growth factor P40 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to stimulate the proliferation of human MO7e cells. The expected ED50 is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 3578 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 39 kDa |
|---|---|
| Numéro d'enregistrement | Q00731 |
| Séquence | MAPTTEGEQK SHEVIKFMDV YQRSYCRPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCAGC CNDEALECVP TSESNITMQI MRIKPHQSQH IGEMSFLQHS RCECRPKKDR TKPEKHCEPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml |
| Conjugué | Unconjugated |
| Nom | Mouse VEGF-165, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Vegfa |
| Nom usuel | VEGF-165 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0-5.0 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 22339 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18.7 kDa |
|---|---|
| Numéro d'enregistrement | P09919 |
| Séquence | TPLGPASSLP QSFLLKCLEQ VRKIQGDGAA LQEKLCATYK LCHPEELVLL GHSLGIPWAP LSSCPSQALQ LAGCLSQLHS GLFLYQGLLQ ALEGISPELG PTLDTLQLDV ADFATTIWQQ MEELGMAPAL QPTQGAMPAF ASAFQRRAGG VLVASHLQSF LEVSYRVLRH LAQP |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse NFS-60 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Nom | Human G-CSF, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Csf3 |
| Nom usuel | G-CSF |
| À utiliser avec (application) | ELISA,Functional Assay,Western Blot |
| Alias du gène | C17orf33; colony stimulating factor 3; colony stimulating factor 3 (granulocyte); CSF 3; CSF3; CSF3OS; Csfg; filgrastim; GCSF; G-CSF; Granulocyte colony-stimulating factor; granulocyte-colony stimulating factor; gsf3; lenograstim; MGC45931; MGI-IG; Pluripoietin; RP23-395E10.4 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to stimulate the proliferation of mouse NFS-60 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 1440 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17 kDa |
|---|---|
| Numéro d'enregistrement | Q9Y275 |
| Séquence | AVQGPEETVT QDCLQLIADS ETPTIQKGSY TFVPWLLSFK RGSALEEKEN KILVKETGYF FIYGQVLYTD KTYAMGHLIQ RKKVHVFGDE LSLVTLFRCI QNMPETLPNN SCYSAGIAKL EEGDELQLAI PRENAQISLD GDVTFFGALK LL |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by a mouse splenocyte survival assay. The expected ED50 for this effect is 0.5-2.0 ug/ml |
| Conjugué | Unconjugated |
| Nom | Human BAFF (BLyS), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | TNFSF13B |
| Nom usuel | BAFF (BLyS) |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | ApoL related ligand TALL-1; b cell-activating factor; B lymphocyte stimulator; BAFF; B-cell-activating factor; B-lymphocyte stimulator; BLYS; CD257; D8Ertd387e; delta BAFF; Delta4 BAFF; dendritic cell-derived TNF-like molecule; DTL; RGD1561519; TALL1; TALL-1; THANK; TNF- and APOL-related leukocyte expressed ligand 1; TNF and ApoL-related leukocyte expressed ligand 1; TNF homolog that activates apoptosis; Tnfsf13b; TNFSF20; TNLG7A; tumor necrosis factor (ligand) superfamily member 13 b; tumor necrosis factor (ligand) superfamily, member 13 b; tumor necrosis factor (ligand) superfamily, member 20; tumor necrosis factor ligand 7 A; tumor necrosis factor ligand superfamily member 13 B; Tumor necrosis factor ligand superfamily member 13 b, membrane form; Tumor necrosis factor ligand superfamily member 13 b, soluble form; tumor necrosis factor superfamily member 13 b; tumor necrosis factor-like protein ZTNF4; UNQ401/PRO738; ZTNF4 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by a mouse splenocyte survival assay. The expected ED50 for this effect is 0.5-2.0 ug/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 10673 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18 kDa |
|---|---|
| Numéro d'enregistrement | P01583 |
| Séquence | SAPFSFLSNV KYNFMRIIKY EFILNDALNQ SIIRANDQYL TAAALHNLDE AVKFDMGAYK SSKDDAKITV ILRISKTQLY VTAQDEDQPV LLKEMPEIPK TITGSETNLL FFWETHGTKN YFTSVAHPNL FIATKQDYWV CLAGGPPSIT DFQILENQA |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse D10S cells. The expected ED50 is ≤0.001 ng/ml, corresponding to a specific activity of ≥1 x 10^9 units/mg |
| Conjugué | Unconjugated |
| Nom | Human IL-1 alpha, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Il1a |
| Nom usuel | IL-1 alpha |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | CTLA8; hematopoietin-1; IL 1 A; IL 1 A; IL1; IL-1 alpha; IL17; IL1A; Il-1 A; IL-1 alpha; IL1-ALPHA; IL1F1; IL1a; ILN; Interleukin; interleukin 1 alpha; interleukin 1, alpha; interleukin 17; interleukin 1 A; interleukin 1-alpha; interleukin 1-alpha (AA 1 - 152); Interleukin1 alpha; interleukin-1 alpha; interleukin-1 alpha precursor; Interleukin-17 A; preinterleukin 1 alpha; pre-interleukin-1 alpha; pro-interleukin-1-alpha; RP23-160G19.8 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to stimulate the proliferation of mouse D10S cells. The expected ED50 is ≤0.001 ng/ml, corresponding to a specific activity of ≥1 x 10^9 units/mg |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 3552 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 8.6 kDa |
|---|---|
| Numéro d'enregistrement | P13500 |
| Séquence | QPDAINAPVT CCYNFTNRKI SVQRLASYRR ITSSKCPKEA VIFKTIVAKE ICADPKQKWV QDSMDHLDKQ TQTPKT |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to chemoattract human monocytes using a concentration range of 10.0-100.0 ng/ml |
| Conjugué | Unconjugated |
| Nom | Human CCL2 (MCP-1), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Ccl2 |
| Nom usuel | CCL2 (MCP-1) |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | Acidic seminal fluid protein; AI323594; C-C motif chemokine 2; C-C motif chemokine ligand 2; Ccl2; chemokine (C-C motif) ligand 2; GDCF-2; HC11; H-MCP-1; HSMCR30; immediate-early serum-responsive JE protein; immediate-early serum-responsive protein JE; Je; MCAF; Mcp1; MCP-1; MCP1A; MCP-1 A; MGC9434; Monocyte chemoattractant protein 1; monocyte chemoattractant protein-1; monocyte chemotactic and activating factor; Monocyte chemotactic protein 1; monocyte chemotactic protein 1 A; Monocyte secretory protein JE; monocyte-chemoattractant protein-1 precursor; platelet-derived growth factor-inducible protein JE; RP23-350G1.3; SCYA2; Sigje; small inducible cytokine A2; small inducible cytokine A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je); small inducible cytokine subfamily A (Cys-Cys), member 2; small inducible gene JE; small-inducible cytokine A2; SMC-CF |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to chemoattract human monocytes using a concentration range of 10.0-100.0 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 6347 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 33.8 kDa |
|---|---|
| Numéro d'enregistrement | Q9H293 |
| Séquence | MYSHWPSCCP SKGQDTSEEL LRWSTVPVPP LEPARPNRHP ESCRASEDGP LNSRAISPWR YELDRDLNRL PQDLYHARCL CPHCVSLQTG SHMDPRGNSE LLYHNQTVFY RRPCHGEKGT HKGYCLERRL YRVSLACVCV RPRVMG |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to induce IL-8 in. human PBMCs using a concentration range of 10-100 ng. |
| Conjugué | Unconjugated |
| Nom | Human IL-17 E (IL-25), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IL25 |
| Nom usuel | IL-25 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | D17Wsu104e; il 17 e; Il17e; IL-17 E; Il25; IL-25; ILN; Interleukin; interleukin 17 E; interleukin 25; interleukin-17 E; Interleukin-25; Ly6elg; Mydgf; myeloid derived growth factor; myeloid-derived growth factor; RGD1561632; UNQ3120/PRO10272; UPF0556 protein C19orf10 homolog |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to induce IL-8 in. human PBMCs using a concentration range of 10-100 ng. |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 64806 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 12.4 kDa |
|---|---|
| Numéro d'enregistrement | Q14005 |
| Séquence | SAASASAASD VSVESTAEAT VCTVTLEKMS AGLGFSLEGG KGSLHGDKPL TINRIFKGAA SEQSETVQPG DEILQLGGTA MQGLTRFEAW NIIKALPDGP VTIVIRRKSL QSKETTAAGD S |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to chemoattract human peripheral blood lymphocytes using a concentration range of 50.0-1000.0 ng/ml |
| Conjugué | Unconjugated |
| Nom | Human IL-16 (121 aa), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IL16 |
| Nom usuel | IL-16 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | FLJ16806; FLJ42735; FLJ44234; H-IL-16; il 16; Il16; IL-16; ILN; Interleukin; interleukin 16; Interleukin16; Interleukin-16; LCF; Lymphocyte chemoattractant factor; M-IL-16; mKIAA4048; neuronal interleukin 16; NIL16; PRIL16; prIL-16; prointerleukin 16; Pro-interleukin-16 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to chemoattract human peripheral blood lymphocytes using a concentration range of 50.0-1000.0 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 3603 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 26 kDa |
|---|---|
| Numéro d'enregistrement | P12643, P21274, P49001 |
| Séquence | MQAKHKQRKR LKSSCKRHPL YVDFSDVGWN DWIVAPPGYH AFYCHGECPF PLADHLNSTN HAIVQTLVNS VNSKIPKACC VPTELSAISM LYLDENEKVV LKNYQDMVVE GCGCR |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 0.5-1.0 ug/ml |
| Conjugué | Unconjugated |
| Nom | Human/Mouse/Rat BMP-2, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | BMP2 |
| Nom usuel | BMP-2 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | 2610024H22Rik; AI467020; AL117858; AW546137; BB189135; BDA2; BMP; BMP2; BMP-2; BMP2A; BMP-2 A; BMPRII; BMPR-II; Bone morphogenetic protein; Bone morphogenetic protein 2; bone morphogenetic protein 2 precursor (BMP-2) (BMP-2 A); bone morphogenetic protein 2 A; H-BMP-2; morphogen |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 0.5-1.0 ug/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 12156, 29373, 650 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17 kDa |
|---|---|
| Numéro d'enregistrement | Q9NZH8 |
| Séquence | SMCKPITGTI NDLNQQVWTL QGQNLVAVPR SDSVTPVTVA VITCKYPEAL EQGRGDPIYL GIQNPEMCLY CEKVGEQPTL QLKEQKIMDL YGQPEPVKPF LFYRAKTGRT STLESVAFPD WFIASSKRDQ PIILTSELGK SYNTAFELNI ND |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Measured by its ability to induce IL-8 production by human PBMCs. |
| Conjugué | Unconjugated |
| Nom | Human IL-36 gamma (IL-1F9), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IL36G |
| Nom usuel | IL1F9 |
| À utiliser avec (application) | ELISA,Functional Assay,Western Blot |
| Alias du gène | IL-1 epsilon; IL-1 related protein 2; IL-1(EPSILON); IL1E; IL-1-epsilon; IL1F9; IL-1F9; IL1H1; IL-1H1; IL-1-related protein 2; IL1RP2; IL-1 RP2; IL36G; Interleukin; interleukin 1 family, member 9; interleukin 1-related protein 2; interleukin 36, gamma; interleukin-1 epsilon; Interleukin-1 family member 9; interleukin-1 homolog 1; Interleukin-36; Interleukin-36 gamma; UNQ2456/PRO5737 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Activité | Measured by its ability to induce IL-8 production by human PBMCs. |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 56300 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 19.8 kDa |
|---|---|
| Numéro d'enregistrement | Q8IU54 |
| Séquence | PTSKPTTTGK GCHIGRFKSL SPQELASFKK ARDALEESLK LKNWSCSSPV FPGNWDLRLL QVRERPVALE AELALTLKVL EAAAGPALED VLDQPLHTLH HILSQLQACI QPQPTAGPRP RGRLHHWLHR LQEAPKKESA GCLEASVTFN LFRLLTRDLK YVADGNLCLR TSTHPEST |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/ μg |
| Activité biologique | Determined by its ability to activate STAT phosphorylation in an ISRE Luciferase Reporter Assay using human colon carcinoma COLO205 cells. The expected ED50 is 0.2-0.5 ng/ml |
| Conjugué | Unconjugated |
| Nom | Human IL-29 (IFN lambda-1), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IFNL1 |
| Nom usuel | IL-29 |
| À utiliser avec (application) | Functional Assay |
| Alias du gène | cytokine Zcyto21; Cytokine Zcyto22; FNL1; IFN lambda1; IFNL1; IFNL3; IFN-lambda-1; IFN-lambda-3; IFN-lambda-4; IL28B; IL-28 B; IL28C; IL-28 C; IL29; IL-29; ILN; interferon lambda 1; interferon lambda 3; Interferon lambda1; interferon lambda-1; Interferon lambda-3; interferon, lambda 1; interferon, lambda 3; interferon, lambda 4; interferon-lambda-1; Interleukin; interleukin 29 (interferon, lambda 1); interleukin-28 B; Interleukin-28 C; interleukin-29; ZCYTO21; ZCYTO22 |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by its ability to activate STAT phosphorylation in an ISRE Luciferase Reporter Assay using human colon carcinoma COLO205 cells. The expected ED50 is 0.2-0.5 ng/ml |
| Système d’expression | E. coli |
| Méthode de purification | HPLC, SDS-PAGE |
| ID du gène (Entrez) | 282618 |
| Formule | protein with no preservative |
| Recombinant | Recombinant |